BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou GX, Huang JF, Li ZS, Xu GM, Liu F, Zhang H. Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer. World J Gastroenterol 2004; 10(9): 1337-1340 [PMID: 15112354 DOI: 10.3748/wjg.v10.i9.1337]
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1337.htm
Number Citing Articles
1
Thomas Illmer, Christian Thiede, Anke Fredersdorf, Sylvia Stadler, Andreas Neubauer, Gerhard Ehninger, Markus Schaich. Activation of the RAS Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia BlastsClinical Cancer Research 2005; 11(9): 3217 doi: 10.1158/1078-0432.CCR-04-2232
2
Mukesh Verma. Pancreatic Cancer EpidemiologyTechnology in Cancer Research & Treatment 2005; 4(3): 295 doi: 10.1177/153303460500400309
3
William R Brugge. Diagnosis and management of relapsing pancreatitis associated with cystic neoplasms of the pancreasWorld Journal of Gastroenterology 2008; 14(7): 1038-1043 doi: 10.3748/wjg.14.1038
4
Michelle Reid. Cytology of the Pancreas: A Practical Review for CytopathologistsSurgical Pathology Clinics 2011; 4(2): 651 doi: 10.1016/j.path.2011.03.006
5
Tatsuo Hata, Masaharu Ishida, Fuyuhiko Motoi, Takuhiro Yamaguchi, Takeshi Naitoh, Yu Katayose, Shinichi Egawa, Michiaki Unno. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysisPancreatology 2016; 16(3): 372 doi: 10.1016/j.pan.2016.01.007
6
Yoshiaki Murakami, Kenichiro Uemura, Tamito Sasaki, Yasuo Hayashidani, Takeshi Sudo, Taijiro Sueda. Long-term survival of pancreatic cancer patient diagnosed by positive telomerase activity of pancreatic juiceSurgery 2005; 138(5): 962 doi: 10.1016/j.surg.2005.07.031
7
Marian Smoczynski, Anna Jablonska, Anita Matyskiel, Joanna Lakomy, Michal Dubowik, Iwona Marek, Wojciech Biernat, Janusz Limon. Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary stricturesGastrointestinal Endoscopy 2012; 75(1): 65 doi: 10.1016/j.gie.2011.08.040
8
Shang-Long Liu, Ge Chen, Yu-Pei Zhao, Wen-Ming Wu, Tai-Ping Zhang. Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysisHepatobiliary & Pancreatic Diseases International 2013; 12(5): 458 doi: 10.1016/S1499-3872(13)60073-9
9
Milton T. Smith. Multimodality Management of Borderline Resectable Pancreatic Cancer2016; : 51 doi: 10.1007/978-3-319-22780-1_4
10
Douglas G. Adler, Todd H. Baron, Raquel E. Davila, James Egan, William K. Hirota, Jonathan A. Leighton, Waqar Qureshi, Elizabeth Rajan, Marc J. Zuckerman, Robert Fanelli, Jo Wheeler-Harbaugh, Douglas O. Faigel. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreasGastrointestinal Endoscopy 2005; 62(1): 1 doi: 10.1016/j.gie.2005.04.015
11
William R. Brugge. ERCP2008; : 467 doi: 10.1016/B978-1-4160-4271-6.50049-6
12
Huajian Gu, Xiaoyan Xin, Yaozhen Pan, Hong Zhang, She Tian, Chengyi Sun. Telomerase Activity as a Marker for Differential Diagnosis of Pancreatic Adenocarcinoma: A Systematic Review and Meta-AnalysisThe International Journal of Biological Markers 2016; 31(2): 126 doi: 10.5301/jbm.5000172
13
Jian Shen, David W. Kindelberger. Cytology2009; : 385 doi: 10.1016/B978-1-4160-5329-3.00013-X
14
William Greenhalf, John Neoptolemos. Pancreatic Cancer2010; : 1203 doi: 10.1007/978-0-387-77498-5_51
15
Mert Erkan, Tania Brocks, Helmut Friess. Cancer Targeted Drug Delivery2013; : 309 doi: 10.1007/978-1-4614-7876-8_12
16
Songting Shou, Yuanliang Li, Jiaqin Chen, Xing Zhang, Chuanlong Zhang, Xiaochen Jiang, Fudong Liu, Li Yi, Xiyuan Zhang, En Geer, Zhenqing Pu, Bo Pang. Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomeraseCancer Gene Therapy 2024;  doi: 10.1038/s41417-024-00768-6